Prosecution Insights
Last updated: April 19, 2026

Examiner: UNDERDAHL, THANE E

Tech Center 1600 • Art Units: 1651 1657 1699

This examiner grants 59% of resolved cases

Performance Statistics

58.7%
Allow Rate
-1.3% vs TC avg
571
Total Applications
+50.4%
Interview Lift
1373
Avg Prosecution Days
Based on 537 resolved cases, 2023–2026

Rejection Statute Breakdown

3.9%
§101 Eligibility
13.3%
§102 Novelty
39.5%
§103 Obviousness
23.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17797241 ANGIOGENESIS DEVICE Non-Final OA TOHOKU UNIVERSITY
19089124 Microbial Conversion of CO2 and Other C1 Substrates to Vegan Nutrients, Fertilizers, Biostimulants, and Systems for Accelerated Soil Carbon Sequestration Non-Final OA Kiverdi, Inc.
19089115 Microbial Conversion of CO2 and Other C1 Substrates to Vegan Nutrients, Fertilizers, Biostimulants, and Systems for Accelerated Soil Carbon Sequestration Non-Final OA Kiverdi, Inc.
17866522 Microbial Conversion of CO2 and Other C1 Substrates to Vegan Nutrients, Fertilizers, Biostimulants, and Systems for Accelerated Soil Carbon Sequestration Final Rejection Kiverdi, Inc.
18260041 BIOLOGICAL SEED-COATING AGENT (SCA) INCLUDING FERMENTATION BROTH OBTAINED BASED ON CO-CULTIVATION OF TRICHODERMA AND BACILLUS SEQUENTIALLY INOCULATED, AND PREPARATION METHOD THEREOF Non-Final OA SHANGHAI JIAO TONG UNIVERSITY
18358437 ENHANCED DETECTION OF BIOFILM-EMBEDDED AND ADHERED PATHOGENS ON CONTAMINATED FOODS OR SURFACES USING ENZYMES Non-Final OA UNIVERSITY OF VIRGINIA PATENT FOUNDATION
18151935 AIR TO LIQUID MICRO-FLUIDIC CHAMBER Non-Final OA Government of the United States as represented by the Secretary of the Air Force
18153476 USE OF CYANOBACTERIA AS A COVER CROP Final Rejection BIODEL AG INC.
17796436 METHOD OF TREATING PANCREATIC CANCER Final Rejection CEDARS-SINAI MEDICAL CENTER
17365027 ECONOMIC SUGAR STREAM, PROCESSES AND SYSTEMS OF PRODUCING SAME Final Rejection POET Research, Inc.
18405956 COMPOUND AND METHOD FOR AN ALLELE-SPECIFIC EDITING OF THE ELANE GENE Non-Final OA Eberhard Karls Universität Tübingen Medizinische Fakultät
18573536 METHOD FOR PRODUCING CARTILAGE CELL STRUCTURE DERIVED FROM iPS CELL Non-Final OA SAGA UNIVERSITY
18504080 PLATELET DERIVATIVES FOR TREATING COAGULOPATHY Non-Final OA Cellphire, Inc.
18252254 THERAPEUTIC APPLICATION OF CELL-FREE FAT EXTRACT TO ARTHRITIS Non-Final OA SHANGHAI SEME CELL TECHNOLOGY CO., LTD.
18040466 Therapeutic Use of Cell-free Fat Extract Solution for Pulmonary Diseases Final Rejection SHANGHAI SEME CELL TECHNOLOGY CO., LTD.
18031793 USE OF MICROORGANISMS AND CALCIUM FOR IMPROVED PLANT HELATH AND/OR RESILIENCE AGAINST PLANT PATHOGENS Final Rejection Valibiotics GmbH
17927714 BIOMARKER COMPOSITION FOR PREDICTING PROGNOSIS OF BRAIN DISEASE CAUSED BY MICROPLASTIC EXPOSURE AND METHOD FOR PREDICTING PROGNOSIS USING SAME Non-Final OA KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
17835208 METHODS OF TREATING CANCER PATIENTS WITH RAS NODE OR RTK TARGETED THERAPEUTIC AGENTS Non-Final OA Celcuity Inc.
17779709 METHODS EMPLOYING GASEOUS NITRIC OXIDE FOR INHIBITING TUMOR GROWTH Non-Final OA Beyond Air, Inc.
17402535 METHODS FOR USING ANTIMICROBIAL COMPOSITIONS Non-Final OA Next Science IP Holdings Pty Ltd

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month